28 August, 2014 10:35 IST
News
Aurobindo gains on USFDA approval for Oxacillin
Source: IRIS (21-JAN-13)
Comments  |  Post Comment

Aurobindo Pharma, a mid-size pharmaceutical company, gained on Monday after it has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Oxacillin for Injection USP, packaged in 1g and 2g vials and Oxacillin for Injection USP 10g/Vial pharmacy bulk package.

Oxacillin for Injection USP is a sterile semisynthetic penicillin (SSP) indicated in the treatment of infections caused by penicillinase producing staphylococci which have demonstrated susceptibility to the drug.

Shares of the company are trading at Rs 195.70, up Rs 3.1, or 1.61% at the Bombay Stock Exchange (BSE) on Monday at 11:42 a.m.

The scrip has touched an intra-day high of Rs 196.70 and low of Rs 193.10. The total volume of shares traded at the BSE is 105,697.

In the earlier session, the shares gained 2.15%, or Rs 4.05, at Rs 192.60. Currently, the stock is trading down 4.49% from its 52-week high of Rs 204.90 and above 104.81% over the 52-week low of Rs 95.55.



Share Price Movement
Period Price
in Rs
Gain/(Loss)
in Rs in %
1 Week 184.55 8.05 4.36
1 Month 195.10 (2.50) (1.28)
3 Months 156.80 35.80 22.83
6 Months 108.40 84.20 77.68
1 Year 100.10 92.50 92.41
Note: Based on previous day closing price.


Aurobindo Pharma Limited   (Q,N,C,F)*


Sector News
Ranbaxy, Sun Pharma receives communication from CCI for their merger - 28-Aug-2014 10:29
Eros International and Maddock Films partner for Badlapur - 28-Aug-2014 10:24
Piramal Enterprises gains after forming JV with Navin Fluorine - 28-Aug-2014 10:04
Piramal Enterprises forms JV with Navin Fluorine - 28-Aug-2014 09:56
RBI asks FIIs to take approval for further investment in UPL - 27-Aug-2014 19:26
IIFL's 12 large cap picks with 35-34% upside potential - 27-Aug-2014 18:15
Mumbai likely to witness increase in new project: CBRE - 27-Aug-2014 15:43
DLF plunges after SC upholds Rs 6.3 bn CCI fine - 27-Aug-2014 15:41
SC upholds Rs 6.30 bn CCI fine on DLF - 27-Aug-2014 15:02
Shree Cement deserves premium valuation, says ICICIdirect - 27-Aug-2014 14:13
RCom plans to reduce debt by Rs 150 bn: Report - 27-Aug-2014 14:08
more...
* Q - Quote , N - News , C - Chart , F - Financials
Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type   q4dv63 into this box
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Forums  |   E-mail  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer